Literature DB >> 28766203

Lobular Neoplasia and Atypical Ductal Hyperplasia on Core Biopsy: Current Surgical Management Recommendations.

Jennifer M Racz1, Jodi M Carter1, Amy C Degnim2.   

Abstract

Entities:  

Mesh:

Year:  2017        PMID: 28766203     DOI: 10.1245/s10434-017-5978-0

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


× No keyword cloud information.
  4 in total

1.  Accuracy of Distinguishing Atypical Ductal Hyperplasia From Ductal Carcinoma In Situ With Convolutional Neural Network-Based Machine Learning Approach Using Mammographic Image Data.

Authors:  Richard Ha; Simukayi Mutasa; Eduardo Pascual Van Sant; Jenika Karcich; Christine Chin; Michael Z Liu; Sachin Jambawalikar
Journal:  AJR Am J Roentgenol       Date:  2019-03-12       Impact factor: 3.959

2.  Atypical ductal hyperplasia bordering on DCIS on core biopsy is associated with higher risk of upgrade than conventional atypical ductal hyperplasia.

Authors:  Kate R Pawloski; Nicole Christian; Andrea Knezevic; Hannah Y Wen; Kimberly J Van Zee; Monica Morrow; Audree B Tadros
Journal:  Breast Cancer Res Treat       Date:  2020-08-28       Impact factor: 4.872

3.  Diagnostic value of radiomics and machine learning with dynamic contrast-enhanced magnetic resonance imaging for patients with atypical ductal hyperplasia in predicting malignant upgrade.

Authors:  Roberto Lo Gullo; Kerri Vincenti; Carolina Rossi Saccarelli; Peter Gibbs; Michael J Fox; Isaac Daimiel; Danny F Martinez; Maxine S Jochelson; Elizabeth A Morris; Jeffrey S Reiner; Katja Pinker
Journal:  Breast Cancer Res Treat       Date:  2021-01-20       Impact factor: 4.872

4.  Prognostic Significance of Lobular Carcinoma In-Situ (LCIS) Diagnosed Alongside Invasive Breast Cancer.

Authors:  Maxwell C Braasch; Amanda L Amin; Christa R Balanoff; Jamie L Wagner; Kelsey E Larson
Journal:  Breast Cancer (Auckl)       Date:  2022-03-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.